Back to Screener

Healthcare

Novavax, Inc.(NVAX)

Live Price

Offline

$8.55

-3.93% today

Window Change

-16.77%

Window

May 29, 2026 โ†’ Jun 18, 2026

Market Cap
$1.31B
Revenue Growth
+64.7%
EPS Growth
+321.1%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 15 bars ยท May 29, 2026 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Novavax, Inc. (NVAX) is a Healthcare stock with a market cap of $1.31B and listed on NASDAQ. The stock last traded around $8.55 and down 16.8% across the available one-year price window (May 29, 2026 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +64.7%, EPS growth of +321.1%, a dividend yield of 0.0%. What stands out right now is revenue +64.7%, EPS +321.1%, free cash flow -149.4% with operating margin 41.3% and ROIC 64.3%. Valuation is more restrained than many high-expectation growth names at P/E 3.0 and price/sales 1.2. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines NVAX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

NVAX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

NVAX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

NVAX Max Drawdown

-21.97%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for NVAX and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 14, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 14, 26
โ€”
Est -0.31
โ€”
โ€”
Est 79307.4B
โ€”
May 14
โ€”
Feb 26, 26
โœ“
0.11
Est -0.66
+116.7%
147139.0B
Est 89847.1B
+63.8%
Feb 26
โ€”
Nov 6, 25
โœ“
-0.62
Est -1.08
+42.6%
70445.0B
Est 90258.5B
-21.9%
Nov 6
โ€”
Aug 6, 25
โœ“
0.62
Est -0.07
+985.7%
239240.0B
Est 55630.0B
+330.1%
Aug 6
โ€”
May 8, 25
โœ“
2.93
Est 0.71
+312.7%
666655.0B
Est 343850.0B
+93.9%
May 8
โ€”
Feb 27, 25
โœ“
-0.51
Est -0.75
+32.0%
88311.0B
Est 84380.0B
+4.7%
Feb 27
โ€”
Nov 12, 24
โœ“
-0.76
Est -0.87
+12.6%
84512.0B
Est 90925.0B
-7.0%
Nov 12
โ€”
Aug 8, 24
โœ—
0.99
Est 1.64
-39.6%
415484.0B
Est 458570.0B
-9.4%
Aug 8
โ€”
May 10, 24
โœ—
-1.05
Est -1.04
-1.0%
93855.0B
Est 101160.0B
-7.2%
May 10
โ€”
Feb 28, 24
โœ—
-1.44
Est -0.49
-193.9%
291342.0B
Est 321970.0B
-9.5%
Feb 28
โ€”
Nov 9, 23
โœ“
-1.26
Est -1.82
+30.8%
22064.0B
Est 321650.0B
-93.1%
Nov 9
โ€”
Aug 8, 23
โœ“
0.58
Est -1.39
+141.7%
424426.0B
Est 239160.0B
+77.5%
Aug 8
โ€”
May 9, 23
โœ—
-3.41
Est -3.38
-0.9%
80951.0B
Est 87610.0B
-7.6%
May 9
โ€”
Feb 28, 23
โœ—
-2.28
Est -0.92
-147.8%
287826.0B
Est 383143.2B
-24.9%
Feb 28
โ€”
Nov 8, 22
โœ—
-2.15
Est 2.21
-197.3%
734577.0B
Est 586248.4B
+25.3%
Nov 8
โ€”
Aug 8, 22
โœ—
-6.53
Est 5.51
-218.5%
185925.0B
Est 863682.7B
-78.5%
Aug 8
โ€”
May 9, 22
โœ—
2.56
Est 2.69
-4.8%
703971.0B
Est 845201.8B
-16.7%
May 9
โ€”
Feb 28, 22
โœ—
-11.18
Est -1.43
-681.8%
222200.0B
Est 331789.8B
-33.0%
Feb 28
โ€”
Nov 4, 21
โœ—
-4.31
Est -4.04
-6.7%
178844.0B
Est 334620.0B
-46.5%
Nov 4
โ€”
Aug 5, 21
โœ—
-4.75
Est -3.76
-26.3%
298017.0B
Est 387870.0B
-23.2%
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener